Dementia with Lewy bodies is a complex neurodegenerative condition often misdiagnosed as Alzheimer's disease.
In short: Memory loss is not always the first sign of this common but elusive dementia. Instead, patients often experience vivid visual hallucinations, fluctuating alertness, and a specific sleep disorder where they act out their dreams. Because symptoms vary wildly, diagnosis remains a significant clinical challenge for modern medicine.
Dementia with Lewy bodies (DLB) is a progressive neurodegenerative disease characterized by the abnormal accumulation of alpha-synuclein protein in the brain. These deposits, known as Lewy bodies and Lewy neurites, disrupt the central and autonomic nervous systems. While the exact cause remains unknown, the condition is classified as a synucleinopathy, sharing pathological features with Parkinson's disease. Unlike Alzheimer's, where memory loss is a hallmark, DLB often presents with fluctuating cognition, attention deficits, and executive dysfunction early in its course.
A defining feature of the disease is REM sleep behavior disorder (RBD), where individuals lose normal muscle paralysis during sleep and physically act out dreams. This can manifest decades before cognitive decline, making it a critical early warning sign. Other core symptoms include recurrent, detailed visual hallucinations—often involving people or animals—and parkinsonism, such as rigidity or slowness of movement. Because these symptoms overlap with other conditions, a definitive diagnosis typically requires an autopsy, though clinicians use biomarkers and imaging to support a presumptive diagnosis.
The disease's impact extends far beyond the brain. Autonomic dysfunction is common, affecting everything from heart rate and blood pressure to gastrointestinal processes like digestion and bowel function. Psychiatric symptoms, including depression, anxiety, and apathy, are also prevalent and can significantly impair quality of life. Management is notoriously difficult; for instance, antipsychotics, often used to treat hallucinations in other conditions, can trigger severe, potentially fatal reactions in nearly half of DLB patients. Consequently, treatment focuses on symptom relief, such as using donepezil or rivastigmine to support cognitive function, while navigating the complex, multi-system nature of the pathology.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Dementia with Lewy bodies
- Also: Neuropathological correlates of imaging in dementia with Lewy bodies.
- Also: Europe PMC — Imbalance in excitation and inhibition in sgACC is associated with depression in dementia with Lewy bodies · CC BY
To cite this card, link to https://intellectplus.co.uk/app/health-dementia-with-lewy-bodies.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Health, medicine and disease · More in Health · Latest · A–Z · All topics
